BCCIP Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BCCIP Antibody
Background:
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene.NCBI Gene ID:
56647Swiss Prot:
Q9P287Host:
RabbitReactivity:
Human, Mouse, RatImmunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 1-314 of human BCCIP (NP_510868.1) .Clonality:
PolyclonalConjugation:
UnconjugatedType:
Primary AntibodiesField of Research:
Cancer, Cell Cycle, Chemokines & Cytokines, ImmunologyPurification:
Affinity purificationPositive Control:
SKOV3Concentration:
Batch dependentBuffer:
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.Modification:
NoneShipping Conditions:
Blue IceStorage Conditions:
Store at -20˚ C. Avoid freeze / thaw cycles.Calculated Molecular Weight:
Observed: 50kDaFragment:
IgGSymbol:
BCCIPPositive Control 2:
HeLaPositive Control 3:
Mouse brainPositive Control 4:
Mouse liverPositive Control 5:
Mouse small intestineNCBI Official Name:
BRCA2 and CDKN1A interacting proteinNCBI Organism:
Homo sapiensOther Product Names:
TOK-1, TOK1, BRCA2 and CDKN1A-interacting protein, BCCIPalpha, BCCIPbeta, BRCA2 and Cip1/p21 interacting protein, TOK-1alpha, TOK-1beta, cdk inhibitor p21 binding protein, p21- and CDK-associated protein 1, protein TOK-1Tested Applications:
WB, IHCPhysical Properties:
Liquid
